What medication is recommended for motion sickness in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Motion Sickness Treatment in Children

For children with motion sickness, dimenhydrinate is the recommended first-line medication, administered at 1.25 mg/kg body weight (or 37.5 mg/m² body surface area) intramuscularly or orally four times daily, with a maximum daily dose not exceeding 300 mg. 1

Age-Specific Safety Considerations

Critical safety warning: Children under 6 years of age should not receive over-the-counter antihistamines for motion sickness due to documented toxicity risks and safety concerns. 2 Between 1969 and 2006, there were 69 fatalities associated with antihistamines in children under 6 years, with 41 deaths occurring in children under 2 years. 2

Medication Options by Age Group

Children ≥6 Years

  • Dimenhydrinate is FDA-approved for prevention and treatment of motion sickness-related nausea, vomiting, and vertigo 1
  • Dosing: 1.25 mg/kg body weight or 37.5 mg/m² body surface area four times daily 1
  • Maximum daily dose: 300 mg 1
  • Expected duration of symptom control: approximately 4 hours per 50 mg dose 1

Children <6 Years

  • Pharmacological treatment is not recommended due to safety concerns 2
  • Non-pharmacological approaches should be prioritized: distraction techniques, audio-visual entertainment, and relaxation methods 2

Mechanism and Efficacy

Antihistamines work by suppressing the central emetic center to relieve nausea and vomiting associated with motion sickness. 3, 4 Under naturally occurring motion conditions, first-generation antihistamines prevent motion sickness symptoms in approximately 40% of susceptible individuals compared to 25% with placebo (moderate-certainty evidence). 5

Administration Guidelines

Intramuscular Route

  • Each milliliter (50 mg) of solution is injected as needed 1
  • Preferred when oral administration is impractical 1

Intravenous Route (if necessary)

  • Each milliliter (50 mg) must be diluted in 10 mL of 0.9% Sodium Chloride Injection 1
  • Inject over a period of 2 minutes 1

Oral Route

  • Can be taken with or without food 1
  • Most practical for routine prevention 1

Important Adverse Effects

Sedation is the most common side effect, occurring in approximately 66% of patients taking antihistamines compared to 44% with placebo. 5 This may be accompanied by drowsiness, which can actually be desirable in some travel situations. 1

Other potential adverse effects include:

  • Blurred vision (14% vs 12.5% placebo) 5
  • Impaired cognition (29% vs 33% placebo) 5
  • Drowsiness and malaise 6

Critical Pitfalls to Avoid

Do not combine multiple motion sickness medications, as this can lead to overdose errors and increased risk of adverse effects. 2

Avoid long-term use of vestibular suppressant medications, as they interfere with central compensation in peripheral vestibular conditions and prevent natural adaptation to motion. 3, 2

Never administer aspirin or aspirin-containing products (such as bismuth subsalicylate) to children ≤18 years with nausea/vomiting due to the risk of Reye's syndrome. 3

Timing of Administration

For optimal prevention, antihistamines should be administered before the anticipated motion exposure rather than after symptoms develop. 6, 7 The medication is most effective when given prophylactically, as treatment of established symptoms is less successful. 6

Behavioral Strategies to Enhance Medication Efficacy

When combined with pharmacotherapy, these strategies improve outcomes:

  • Position child in the most stable part of the vehicle (front seat if age-appropriate, middle of boat) 6
  • Have child watch the true visual horizon 6
  • Encourage lying down with eyes closed 6
  • Minimize exposure to difficult travel conditions 6
  • Reduce other sources of physical and emotional discomfort 6

References

Guideline

Medication Safety and Efficacy for Motion Sickness in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamiento para Cinetosis Severa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Research

Prevention and treatment of motion sickness.

American family physician, 2014

Research

[Motion sickness in motion: from carsickness to cybersickness].

Nederlands tijdschrift voor geneeskunde, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.